For Immediate Release
Contact:
mktgcomm@tams.com
MANHATTAN DIAGNOSTIC RADIOLOGY - CARDIOLOGY CENTER REACHES 500th PATIENT MILESTONE
Physicians Deliver Advanced Cardiac Care Using Toshiba's Aquilion 64-slice CFX CT
TUSTIN, Calif., June 14, 2005 – Manhattan Diagnostic Radiology
(MDR), a dedicated heart center located in New York City, today announced it has
successfully scanned its 500th patient using the center’s state of the
art Aquilion 64-slice CFX from Toshiba America Medical Systems Inc (TAMS).
The announcement, which was made in conjunction with the 7th Annual Stanford
Radiology International Symposium on Multidetector-Row CT, further emphasizes the
impact of 64-slice CT technology on the diagnosis and treatment of cardiovascular
diseases.
During the symposia, Dr. Jeffrey P. Goldman, director of MRI and CT at MDR, will
deliver a lunch-time presentation hosted by Toshiba about the benefits of multi-slice
CT for cardiac applications, his experiences with the Aquilion CFX CT, and its positive
impact on his practice and the care of his patients. The advanced image quality
and speed delivered by the Aquilion CFX allows cardiologists to uncover early signs
of heart disease, such as arterial plaque, and make treatment recommendations without
the need for invasive exploration of the heart. In fact, Dr. Goldman states
that the Aquilion CFX allows clinicians at MDR to identify indications of disease
earlier in its progression, potentially reducing a patient’s risk of suffering a
heart attack or stroke.
“Images of the heart are extremely difficult to capture because it’s in a state
of continuous motion. Until the advent of multi-slice CT, cardiologists had
to rely on more invasive, risky procedures, like catheterized angiography, to give
an accurate view of what was happening inside the patient’s heart,” Goldman said.
“The Aquilion CFX produces brilliant images allowing me to view intricate areas
of the heart, to accurately pinpoint current cardiac issues and to detect potential
problems in the earliest stages—even for patients with a normal stress test.”
According to Doug Ryan, director, CT Business Unit, TAMS, “Manhattan Diagnostic
Radiology (MDR) is a leading imaging center in New York City due to their experience
and ongoing investments in state-of-the-art imaging and diagnostic technologies.
Their recent acquisition of the Aquilion 64-slice CFX is a testament to the commitment
by MDR and the technology of the Aquilion to diagnose the earliest stages of heart
disease and improve cardiac patient care,” Ryan said.
MDR is renowned for its thought leadership in the area of cardiac imaging, as well
as for utilizing the latest cardiac imaging tools to provide patients with a higher
standard of care. Toshiba’s Aquilion 64-slice CFX CT scanner is just one component
of the facility’s suite of imaging technologies. TAMS’ unique 64-row Quantum
detector enables the Aquilion scanner to acquire 64 simultaneous slices of 0.5 mm
of the heart with each 400-millisecond gantry revolution, which allows cardiologists
to scan the heart with superb precision.
The 7th Annual Stanford Radiology International Symposium on Multidetector-Row
CT will be held at the Hyatt Regency in San Francisco on June 15-18, 2005.
For more information about Manhattan Diagnostic Radiology, email
jgoldman@mdrny.com. For more information about TAMS visit
www.medical.toshiba.com.
About Toshiba
With headquarters in Tustin, Calif., Toshiba America Medical Systems Inc. markets,
sells, distributes and services diagnostic imaging systems, and coordinates clinical
diagnostic imaging research for all modalities in the United States. Toshiba
Medical Systems Corporation, an independent group company of Toshiba Corporation,
is a global leading provider of diagnostic medical imaging systems and comprehensive
medical solutions, such as CT, X-ray, Ultrasound, Nuclear Medicine, MRI and information
systems. Toshiba Corporation is a leader in information and communications
systems, electronic components, consumer products, and power systems. Toshiba
has approximately 162,000 employees worldwide and annual sales of $55 billion.